The project Precision Health Research, Singapore, also known as PRECISE, was established to coordinate Singapore’s national effort to implement precision medicine across the healthcare system. Phase III of Singapore’s National Precision Medicine Program has launched, with aims of enrolling up to 450,000 inhabitants to form a genomic database and biobank and to deliver precision medicine at population scale within the healthcare system.
PRECISE began in 2017 with the launch of Phase I of the project, Phase II of the project began in 2021 and was completed earlier this year. Phase III of the project will run until 2031. In addition to collecting genomic information from more people and assessing how precision medicine can be rolled out on a larger scale in Singapore, it also aims to support preventive care by giving doctors and patients genetic insights that allow earlier diagnosis, followed by targeted therapies, and personalized interventions.
【MORE】